
		<paper>
			<loc>https://jjcit.org/paper/301</loc>
			<title>ADVANCEMENTS IN AI-DRIVEN DIABETIC RETINOPATHY DETECTION: A SYSTEMATIC SURVEY DIRECTIONS</title>
			<doi>10.5455/jjcit.71-1774477476</doi>
			<authors>Yasser A. Ali,Ahmed Z. Emam,Muhammed H. Zayyan,Samir Elmougy,Ahmed S. Tolba</authors>
			<keywords>Diabetic Retinopathy,Automated Disease Screening,Deep Learning,Artificial Intelligence,Fundus Imaging,Explainable AI,Vision Transformers,Domain Adaptation,Class Imbalance</keywords>
			<views>1197</views>
			<downloads>503</downloads>
			<received_date>25-Mar.-2026</received_date>
			<revised_date>  31-May-2026 and 22-Jun.-2026</revised_date>
			<accepted_date>  30-Jun.-2026</accepted_date>
			<abstract>Diabetic retinopathy (DR) is a leading cause of preventable vision impairment, requiring scalable and reliable 
screening solutions. Artificial intelligence (AI), particularly machine learning and deep learning, has significantly 
advanced the automation of DR classification from retinal fundus images. This paper presents a systematic review 
of AI-based DR classification approaches, focusing on binary classification, multi-class severity grading and 
lesion-based methods and introduces a taxonomy based on their clinical objectives. The review covers state-of-
the-art models, including convolutional neural networks, vision transformers, attention mechanisms and ensemble 
techniques, as well as their pre-processing strategies and evaluation protocols. Common benchmark datasets are 
analyzed in terms of class distribution and their impact on performance. While current models achieve high 
accuracy on standard datasets, challenges remain in generalization, class imbalance and reliable detection of 
early-stage DR. Lesion-based approaches improve interpretability, but are often not fully integrated into grading 
frameworks. Overall, this review highlights key limitations and outlines future directions toward developing 
robust, interpretable and clinically deployable DR classification systems for real-world screening.</abstract>
		</paper>


